Advertisement
Elanco Animal Health Closes Sale Of Aqua Business To Merck Animal Health
(RTTNews) - Elanco Animal Health, Inc. (ELAN) announced Tuesday it has completed the divestiture of its aqua business to Merck Animal Health (MRK) for approximately $1.3 billion in cash, with approximately $1.05 billion to $1.1 billion in net proceeds available for debt paydown in the third quarter of 2024.
The successful completion of this transaction enables the company to pay down term loan debt on a pro-rata basis per the terms of the company's credit agreements.
Combined with the expected $280 million to $320 million of cash generated from the base business, the company expects to pay down approximately $1.3 billion to $1.4 billion of debt in 2024.
read more
Elanco Animal Health Boosts FY23 Adj. EPS, Revenue Outlook As Q3 Results Top Estimates
Elanco Animal Health Inc. (ELAN) reported Tuesday a net loss for the third quarter of $1.10 billion or $2.22 per share, sharply wider than $65.0 million or $0.13 per share in the prior-year quarter.
RTTNews
|
491 дней спустя
Elanco's Canine Parvovirus Treatment Gets USDA License
Elanco Animal Health Inc. announced that the U.S. Department of Agriculture or USDA has issued a conditional license for its Canine Parvovirus Monoclonal Antibody. The company expects to begin shipping Canine Parvovirus Monoclonal Antibody in the coming weeks, pending individual state approvals. The targeted single-dose monoclonal antibody is the first and only approved targeted therapeutic...
RTTNews
|
679 дней спустя
FDA Approves First Drug For Anemia In Cats With CKD
The U.S. Food and Drug Administration conditionally approved Elanco US Inc.'s Varenzin-CA1 (molidustat oral suspension) for treating anemia in cats with chronic kidney disease or CKD. It is the first drug for the control of nonregenerative anemia associated with CKD in cats. Varenzin-CA1 works by helping to increase production of erythropoietin in the kidney, which in turn stimulates the bone mar
RTTNews
|
680 дней спустя
Canadian Stocks Turning In Mixed Performance After BoC Rate Cut, U.S. Inflation Data
Canadian stocks are turning in a mixed performance Wednesday morning with investors digesting the Bank of Canada's interest rate decision, and tamer than expected U.S. consumer price inflation data.
Worries about the U.S. Government's stance on tariffs, and the possibility of recession in the U.S., Canada and Mexico, are weighing on sentiment and limiting market's upside.
RTTNews
|
5ч 16мин назад
Elon Musk's Starlink Partners With India's Jio And Airtel
Close on the heels of signing an agreement with one of India's telecom majors Airtel, Elon Musk's SpaceX signed a deal with the country's another tycoon Jio Platforms Ltd, affiliated to Billionaire Mukesh Ambani's Reliance Industries, to offer Starlink satellite Internet services in the country.
RTTNews
|
6ч 15мин назад
Bank Of Canada Cuts Interest Rates By Another 25 Basis Points
With inflation close to the 2 percent target, the Bank of Canada on Wednesday announced its widely expected decision to lower interest rates by another 25 basis points, making its seventh straight rate cut. The Bank of Canada said it decided to reduce its target for the overnight rate to 2.75 percent, with the Bank Rate at 3 percent and the deposit rate at 2.70 percent.
RTTNews
|
6ч 39мин назад
U.S. Consumer Prices Rise Less Than Expected In February, Annual Growth Slows
A report released by the Labor Department on Wednesday showed consumer prices in the U.S. increased by slightly less than expected in the month of February. The Labor Department said its consumer price index crept up by 0.2 percent in February after climbing by 0.5 percent in January. Economists had expected consumer prices to rise by 0.3 percent.
RTTNews
|
7ч 0мин назад
Bay Street Likely To Open On Positive Note
The Bank of Canada's interest rate decision, and U.S. consumer price inflation data are in focus on Bay Street Wednesday morning. The market looks set to open higher thanks to firm commodity prices and European stocks.
RTTNews
|
7ч 51мин назад
